Holen Sie sich die Stockscreener-App
82.85
0.10%
-0.08
Handel nachbörslich:
82.85
Schlusskurs vom Vortag:
$82.93
Offen:
$83.4
24-Stunden-Volumen:
118.07K
Relative Volume:
0.73
Marktkapitalisierung:
$1.88B
Einnahmen:
$213.03M
Nettoeinkommen (Verlust:
$41.32M
KGV:
45.27
EPS:
1.83
Netto-Cashflow:
$33.49M
1W Leistung:
-0.99%
1M Leistung:
-4.57%
6M Leistung:
-0.56%
1J Leistung:
-14.79%
1-Tages-Spanne:
$82.31
$84.14
1-Wochen-Bereich:
$81.85
$86.96
52-Wochen-Spanne:
$71.42
$105.55
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Firmenname
Lemaitre Vascular Inc
Sektor
Telefon
781-221-2266
Adresse
63 SECOND AVENUE, BURLINGTON, MA
Vergleichen Sie LMAT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
82.85 | 1.88B | 213.03M | 41.32M | 33.49M | 1.83 |
|
ISRG
Intuitive Surgical Inc
|
558.13 | 200.96B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
188.82 | 54.09B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.67 | 38.74B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
246.52 | 36.50B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
266.07 | 19.36B | 2.96B | 487.70M | 344.00M | 6.6758 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2025-02-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2025-02-28 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-02-13 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-10-15 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2024-08-02 | Fortgesetzt | Lake Street | Buy |
| 2024-05-31 | Fortgesetzt | ROTH MKM | Buy |
| 2024-04-26 | Hochstufung | Stifel | Hold → Buy |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-06 | Eingeleitet | Oppenheimer | Outperform |
| 2023-08-03 | Herabstufung | Jefferies | Buy → Hold |
| 2023-05-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | Eingeleitet | Jefferies | Buy |
| 2021-02-12 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | Hochstufung | Sidoti | Neutral → Buy |
| 2019-10-24 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | Hochstufung | Lake Street | Hold → Buy |
| 2019-10-14 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | Bestätigt | Barrington Research | Outperform |
| 2019-07-25 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2018-06-08 | Fortgesetzt | ROTH Capital | Buy |
| 2018-04-26 | Herabstufung | Stifel | Buy → Hold |
| 2018-04-26 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2017-10-27 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-07-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-03-21 | Eingeleitet | First Analysis Sec | Overweight |
| 2017-02-22 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-07-28 | Bestätigt | Barrington Research | Outperform |
| 2016-02-25 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Lemaitre Vascular Inc Aktie (LMAT) Neueste Nachrichten
First Trust Advisors LP Increases Stock Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Dir O'Connor Acquires 1 Of LeMaitre Vascular Inc [LMAT] - TradingView
LeMaitre Vascular, Inc. $LMAT Shares Sold by JPMorgan Chase & Co. - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Cut to Hold at Wall Street Zen - MarketBeat
Quantbot Technologies LP Increases Stock Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Will LeMaitre Vascular Inc. (LHU) stock keep high P E multiplesWeekly Trade Report & Detailed Earnings Play Strategies - Newser
Will LeMaitre Vascular Inc. stock benefit from AI adoptionWeekly Trade Recap & High Return Trade Opportunity Guides - Newser
Why LeMaitre Vascular Inc. (LHU) stock signals breakout potentialTrade Performance Summary & High Win Rate Trade Alerts - Newser
Will LeMaitre Vascular Inc. (LHU) stock enhance shareholder value2025 Fundamental Recap & Weekly Momentum Stock Picks - Newser
Will LeMaitre Vascular Inc. stock outperform value stocks2025 Key Highlights & High Conviction Investment Ideas - Newser
Is LeMaitre Vascular Inc. (LHU) stock attractive post correctionDollar Strength & Long-Term Capital Growth Strategies - Newser
Zacks.com featured highlights include Life Time, Cardinal Health, LeMaitre Vascular and Flowserve - Zacks Investment Research
Is LeMaitre Vascular Inc. (LHU) stock good for wealth creation - Newser
Inceptionr LLC Buys New Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Russell Investments Group Ltd. Cuts Stock Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Grandeur Peak Global Advisors LLC Invests $6.28 Million in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Is LeMaitre Vascular’s Drop an Opportunity After Expansion and Regulatory News? - Yahoo Finance
LeMaitre Vascular (LMAT): A Fresh Look at Valuation After Recent Share Price Weakness - Yahoo Finance
LeMaitre Vascular, Inc. $LMAT Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
Ensign Peak Advisors Inc Has $782,000 Stock Position in LeMaitre Vascular, Inc. $LMAT - Defense World
Reviewing LeMaitre Vascular (NASDAQ:LMAT) & Ayr Wellness (OTCMKTS:AYRWF) - Defense World
Liquidity Mapping Around (LMAT) Price Events - news.stocktradersdaily.com
Will LeMaitre Vascular Inc. stock beat EPS estimates2025 Geopolitical Influence & Technical Pattern Recognition Alerts - moha.gov.vn
LeMaitre to Participate in Upcoming Investor Conferences - Sahm
Here is Why Growth Investors Should Buy LeMaitre (LMAT) Now - Yahoo Finance
Death Cross: How LeMaitre Vascular Inc. (LHU) stock reacts to new regulationsDividend Hike & High Accuracy Trade Alerts - BỘ NỘI VỤ
LeMaitre Vascular, Inc. (LMAT) Stock Forecasts - Yahoo Finance
Geode Capital Management LLC Purchases 15,036 Shares of LeMaitre Vascular, Inc. $LMAT - MarketBeat
Segall Bryant & Hamill LLC Purchases 6,335 Shares of LeMaitre Vascular, Inc. $LMAT - MarketBeat
Intech Investment Management LLC Trims Stock Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Insiders At LeMaitre Vascular Sold US$8.9m In Stock, Alluding To Potential Weakness - simplywall.st
Healthcare Stocks to Avoid: LMAT, CNMD, TECH AnalysisNews and Statistics - IndexBox
What drives LeMaitre Vascular Inc LHU stock priceLarge Cap Stability Picks & Predict Price Movements With AI Precision - earlytimes.in
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
LeMaitre Vascular, Inc. $LMAT Stake Boosted by Bahl & Gaynor Inc. - Defense World
LeMaitre Vascular (NASDAQ:LMAT) Rating Increased to Buy at Wall Street Zen - MarketBeat
Dir O'Connor Acquires 7,500 Of LeMaitre Vascular Inc [LMAT] - TradingView
[Form 4] LEMAITRE VASCULAR INC Insider Trading Activity - Stock Titan
How LeMaitre Vascular Inc. (LHU) stock reacts to fiscal policiesBear Alert & Growth Focused Investment Plans - newser.com
Will LeMaitre Vascular Inc. stock maintain growth story2025 Market Overview & Growth Focused Investment Plans - newser.com
Will LeMaitre Vascular Inc. (LHU) stock benefit from Fed rate cutsTrade Entry Report & Free Daily Entry Point Trade Alerts - newser.com
Can LeMaitre Vascular Inc. (LHU) stock deliver strong annual returnsJuly 2025 Selloffs & Smart Investment Allocation Insights - newser.com
Is LeMaitre Vascular Inc. stock a bargain at current levelsEarnings Overview Report & Risk Controlled Daily Trade Plans - newser.com
Finanzdaten der Lemaitre Vascular Inc-Aktie (LMAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
3.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):